Wednesday - January 14, 2026

Category Archives: Pharmaceuticals & Biotech

Toogood Gold Expands Footprint, Positioned for High-Impact Growth 2026 Alongside: ADMQ, BMXI, CSDX, SIGL

Toogood Gold Corp. (TSXV: TGC | OTCQB: TGGCF) reported final drilling assays from its 100%-owned Toogood Gold Project in Newfoundland, delivering results that significantly expand the scale, continuity, and upside potential of its gold discovery heading into 2026. The Company’s … Continue reading →

Esophageal Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Eli Lilly and Company, Bayer, Zymeworks, Jazz Pharma, Amgen, AstraZeneca, Symphogen, Hoffmann-La Roche

The Key Esophageal Cancer Companies in the market include – Eli Lilly and Company, Bayer, Zymeworks, Jazz Pharmaceuticals, Amgen, Jazz Pharmaceuticals, Zymeworks, BeiGene, AstraZeneca, Symphogen, Hoffmann-La Roche, Eli Lilly and Company, Ipsen, Jacobio Pharmaceuticals Co., Ltd., Shanghai Henlius Biotech, CStone … Continue reading →

Alzheimer’s Disease Market in the 7MM is projected to reach USD 34 Billion by 2034, analyses DelveInsight

Alzheimer’s Disease Market Key players operating in the Alzheimer’s disease market include Eisai, Biogen, Changchun Huayang High-tech Co. Ltd., Hoffmann-La Roche, vTv Therapeutics, AZTherapies, Cerecin, Neurotrope, Lyndra, AC Immune, INmune Bio, Cassava Sciences, EIP Pharma, Neuraly, AB Science, Cortexyme, Anavex … Continue reading →

Glaucoma Market Forecast 2034: USD 4,073 Million Market Size, 30+ Companies, and 15+ Emerging Therapies Shaping Growth, estimates DelveInsight

Glaucoma Market Major Glaucoma players include Allergan (AbbVie), Sun Pharma Advanced Research Company Limited, Santen Pharmaceutical Co., Ltd., Alcon, D. Western Therapeutics Institute (DWTI), Kowa Ltd., Senju Pharmaceuticals, Otsuka Pharmaceuticals, Bausch and Lomb, Novartis, Merck & Co., Aerie Pharmaceuticals, Nicox … Continue reading →

Graves’ Disease Market Size in the 7MM was ~USD 4,400 million in 2023 and is expected to increase with a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Graves’ Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Graves’ Disease, historical and forecasted epidemiology as well as the Graves’ Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the … Continue reading →

Myelofibrosis Market in the 7MM is projected to grow at a CAGR of 9% by 2034, estimates DelveInsight

DelveInsight’s ‘Myelofibrosis Market Insight, Epidemiology, and Market Forecast-2034‘ report delivers an in-depth understanding of myelofibrosis, historical and forecasted epidemiology as well as the myelofibrosis therapeutics market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United … Continue reading →

Acute on Chronic Liver Failure Market Size in the 7MM is expected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Acute on Chronic Liver Failure Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Acute on Chronic Liver Failure, historical and forecasted epidemiology as well as the Acute on Chronic Liver Failure market trends in … Continue reading →

ADM Endeavors (OTCQB: ADMQ) Reports $5.3M Revenue, Expands Operations Supporting 2026 Expansion Alongside EVTV, PASW, BMXI, UP, PNPNF

ADM Endeavors (OTCQB: ADMQ), a diversified direct marketing and value-added manufacturing company, continues to build momentum as its wholly owned subsidiary Just Right Products, Inc., delivers consistent revenue growth, expands into new markets, and significantly scales its operational facility footprint. … Continue reading →

Global Neurofibromatosis Type 2 Pipeline Expands With 5+ Companies Advancing 5+ Therapies, Reveals DelveInsight’s Clinical and Developmental Analysis

Neurofibromatosis Type 2 Pipeline Leading Neurofibromatosis Type 2 Companies include Recursion Pharmaceuticals, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics, AstraZeneca, Fosun Pharmaceutical, NFlection Therapeutics, and several other innovators. The global Neurofibromatosis Type 2 (NF2) therapeutic pipeline is witnessing steady expansion, driven … Continue reading →